RIM
IONS icon

Rockbridge Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Rockbridge Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58
Closed -$2.94K – 365
2023
Q4 		$2.94K Buy
+58
New +$2.78K ﹤0.01% 521
2022
Q3 		– Sell
-58
Closed -$2.15K – 340
2022
Q2 		$2.15K Hold
58
– – ﹤0.01% 538
2022
Q1 		$2.26K Hold
58
– – ﹤0.01% 690
2021
Q4 		$2K Hold
58
– – ﹤0.01% 726
2021
Q3 		$2K Hold
58
– – ﹤0.01% 674
2021
Q2 		$2K Hold
58
– – ﹤0.01% 672
2021
Q1 		$3K Hold
58
– – ﹤0.01% 623
2020
Q4 		$3K Hold
58
– – ﹤0.01% 608
2020
Q3 		$3K Hold
58
– – ﹤0.01% 562
2020
Q2 		$3K Buy
+58
New +$3.23K ﹤0.01% 535

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rockbridge Investment Management's IONS Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2024, closing a stake of 58 shares — an estimated $2.94K sold.

Rockbridge Investment Management first reported a position in IONS in Q2 2020 and held it in 10 quarters. The position peaked at $3K in Q1 2021. 361 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Ionis Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 58 Ionis Pharmaceuticals shares in Q1 2024, an estimated $2.94K.
  • Rockbridge Investment Management first reported a position in Ionis Pharmaceuticals in Q2 2020 and held it in 10 quarters.
  • Rockbridge Investment Management's Ionis Pharmaceuticals position peaked at $3K in Q1 2021.
  • 361 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.